InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Frequently asked questions
What sector does Intercure (INCR) operate in?
Intercure belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Intercure (INCR) current stock price?
As of the latest data, Intercure stock price is ₪13.74, with a previous close of ₪14.50. Intercure lost -₪0.76 in the last trading session, representing a -5.24% loss.
What is Intercure (INCR) current market capitalization?
Intercure market cap is approximately 206.15 million.
What is Intercure (INCR) Earnings Per Share (EPS)?
The trailing EPS is -₪3.28.
Does Intercure (INCR) pay dividends?
No. Intercure does not pay a dividend.
What is Intercure (INCR) beta (volatility) score?
Intercure has a beta of 0.636, indicating lower volatility than the overall market.